Greenlund, Ian M.
Bock, Joshua M.
Govindan, Nivash
Kantas, Dimitrios
Singh, Prachi
Covassin, Naima
Somers, Virend K.
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (T32-DK007013)
National Heart, Lung, and Blood Institute (R01-HL160619, T32-HL007111)
Article History
Received: 23 December 2024
Revised: 4 March 2025
Accepted: 6 March 2025
First Online: 15 March 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board Committee at Mayo Clinic.
: Informed consent was obtained from all individual participants included in the study.
: All participants were informed that their deidentified research information would be used for publications purposes at study consent/enrollment.
: VKS has consulted for Lilly, Zoll, Jazz Pharma, Axsome, and Know Labs and is on the Sleep Number Scientific Advisory Board. All other authors have no relevant conflicts to disclose.